How to Apply Breast Milk to Baby Eczema

Nutrients. 2019 May; eleven(5): 944.

Milk Therapy: Unexpected Uses for Human Breast Milk

Received 2019 Mar 27; Accepted 2019 Apr 25.

Abstract

Background: Homo breast milk provides a kid with complete nutrition but is also a popular therapeutic remedy that has been used in traditional, natural pharmacopeia, and ethnomedicine for many years. The aim of this current review is to summarize studies of non-nutritional uses of mothers' milk. Methods: 2 databases (PubMed and Google Scholar) were searched with a combination of twelve search terms. We selected manufactures that were published between 1 January 2010, and 1 Jan 2019. The linguistic communication of publication was limited to English. Results: 15 studies were included in the systematic review. Ten of these were randomized controlled trials, i was a quasi-experimental report, two were in vitro studies, and iv employed an beast research model. Conclusions: Many man milk components have shown promise in preclinical studies and are undergoing active clinical evaluation. The protective and handling role of fresh breast milk is particularly important in areas where mothers and infants do non have ready access to medicine.

Keywords: homo milk benefits, colostrum, milk therapy, bioactive factors

1. Introduction

Man chest milk (HBM) is peradventure the nearly important functional nutrient known. Information technology is a dynamic nutrient with both nutritional and health benefits for neonates and infants. Homo milk has powerful immunological backdrop, protecting infants from respiratory diseases, eye ear infections, and gastro-abdominal diseases. It is at present appreciated that human breast milk has wellness impacts that are lifelong, with breastfeeding showing protective effects against diabetes mellitus, obesity, hyperlipidemia, hypertension, cardiovascular diseases, autoimmunity, and asthma [1]. However, homo milk is also a pop therapeutic remedy that has been practical as a office of traditional, natural pharmacopeia, and ethnomedicine for many years. Public health nurses have reported on the effects of fresh colostrum and human milk equally a handling for conjunctivitis, chapped nipples, rhinitis, infections of the skin and soft tissues. The discovery of growth factors, cytokines, and a heterogeneous population of cells—including stem cells, probiotic bacteria, and the Hamlet complex (human alpha-lactalbumin made lethal to tumor cells)—in homo milk has led to researchers' increased interest in human breast milk every bit a natural medicine. In contempo years, human milk has been the focus of many types of prove-based research. There accept been a number of reports on the topical application of homo milk every bit an effective treatment for diaper rash, atopic eczema, diaper dermatitis, and umbilical cord separation [ii,3,four]. The protective and treatment function of homo milk is particularly important in areas where mothers and infants do not have ready access to medicine, such as in developing countries. In these situations, milk therapy is often a determining factor of infant recovery and survival. For this reason, more clinical trials and research into mothers' milk come from depression and middle-income countries in Africa and Asia. Many human milk components take shown promise in preclinical studies and are undergoing agile clinical evaluation. A few milk-derived therapeutic preparations are available to clinicians. The written report of homo milk has resulted in abundant opportunities for translational medicine. Yet, complementary and alternative medicine (CAM) therapies oft fare unfavorably under the scrutiny of evidence-based exercise (EBP), due to the lack of or shortage of inquiry and the inherent differences in healing ideology. Yet excess medicalization and pharmaceuticalization tin can lead to the extension of the medical gaze to human conditions. Physically maladaptive outliers have been treated as diseases and pulled into the realm of medicine. Many "non-disease" states tin can creep upwardly into medicine, and with time become medicalized due to the redefining of many conditions that were long considered social or psychological phenomena as disease states. Processes regarded as natural are now looked at medical bug or diseases. Unnecessary medicalization leads to nifty social and financial cost, likewise as increased feet and the risk for complication from further workups for incidental or clinically unimportant findings. The growth of research and reflections on medicalization has led to the proposal of other parallel concepts, such as biomedicalization. These tools could be useful in the analysis of homo enhancement and can be defined every bit contributing to a "bionic society". Medicalization risks neglecting the role of social determinants, natural therapies, and ethnomedicine in shaping human health. On the other hand, where individuals do not have gear up admission to medicine—particularly in developing countries—cognition, skills, and practices based on the theories and experiences indigenous to different cultures, whether explicable or not, are used in the maintenance of health equally well as in the prevention, improvement, and treatment of illness.

At that place is no doubt that incorporating traditional and modern show-based medicine (EBM) as integral parts of the formal health-intendance system is important and likely to be achieved in many countries. The aim of the current review is to summarize studies of non-nutritional usage of mothers' milk. Due to its depression cost, wide availability, and lack of undesirable furnishings, mothers' milk has the potential to play a function in human wellness and in bear witness-based therapy.

2. Methods

The literature review was performed past conducting an electronic search of PubMed and Google Scholar. No filter or limitation was used during the search. Reference lists from selected studies were manually scanned to identify any other relevant studies. The electronic search used the following keywords and medical subject headings (MeSH) terms: Human milk; breast milk, female parent milk, colostrum, atopic eczema, diaper dermatitis, nipple hurting, breast inflammation, umbilical cord separation, neonatal conjunctivitis, HAMLET, topical treatment. The ii authors independently searched databases and reviewed articles. Bibliographic references to retrieved reviews and studies were searched for additional articles. Nosotros included articles that were published between i January 2010, and one Jan 2019. The language of publication was express to English.

From total of 1503 initially screened articles, but fifteen fulfilled all the inclusion criteria. The post-obit criteria needed to be fulfilled for a written report to be included in this review: (1) Topical application of human milk or human milk agile factors versus control; (two) in the example of human studies, participants had to be newborns; (3) in the case of animal models, HBM in vitro assessment had to exist included. Articles that did not provide sufficient information from the title and abstract were included for further evaluation, and reading was done in full. Records were first selected later on which 1469 were excluded based on excluded criteria: Did non written report the data of interest, the language of publication, no access to the total text, briefing proceeding, reviews. There was no brake of report designs included. In order to limit bias in the inclusion–exclusion procedure, the selection was fabricated on the basis of the consensus of 2 authors. The Cohen's kappa index was calculated to assess the agreement betwixt the two reviewers and any discrepancy was resolved by consensus or past a 3rd reviewer. The reviewers were not blind to author, institutions, or manuscript journals. Data extraction and analysis were performed past the same two reviewers. Figure i presents a period diagram of the review process while Tabular array 1 summarizes the studies that were included.

Table i

Articles included in this review, with study details.

References	Intervention/Written report Blazon	Sample Size	The Dropout Rate	Study Design	Outcomes	Main Findings
Berents et al. (2015) [v]	Atopic eczema/Randomized clinical trial	18 participants	33%	HBM or emollient was applied on the spot, three times a 24-hour interval for 4 weeks. The severity and expanse of the eczema spots was calculated weekly by SCORAD.	Both command and intervention areas of the eczema spots were increased during the intervention. At inclusion mean SCORAD (SCORing Atopic Dermatitis) was 35 and at the finish of study 34.	No effect with topical application of HBM was found.
Kasrae et al. (2015) [six]	Atopic eczema/Randomized clinical trial	116 participants	10%	HBM or hydrocortisone i% was applied twice a day for 21 days on the affected area. Efficiency of the handling was defined by SCORAD index.	The frequency of healed infants was 81.5% and 76% in HBM and 1% hydrocortisone groups on 24-hour interval 21, respectively (p < 0.24).	HBM was as effective equally one% hydrocortisone.
Farahani et al. (2013) [7]	Diaper dermatitis/Randomized clinical trial	152 participants	4.6%	HBM or hydrocortisone ane% was applied for seven days on the afflicted area. The efficiency of the treatment was evaluated at 3 and 7 days by a 6-betoken calibration.	The severity score was non different betwixt the topical HBM and hydrocortisone i% groups at 3 and 7 days (p < 0.95).	HBM was as effective every bit one% hydrocortisone.
Gozen et al. (2014) [eight]	Diaper dermatitis/Randomized clinical trial	70 participants	10%	HBM and barrier foam containing xl% zinc oxide and cod liver oil was applied on diaper dermatitis change for 5 days and the postlesion score was establish by a iv-betoken scale.	The status of dermatitis was improved in lx% of infant from HBM grouping and 93.6% treated with barrier cream. The postlesion score of bulwark foam group was lower than HBM group (p = 0.002).	Barrier cream was more effective than HBM.
Seifi et al. (2017) [9]	Diaper dermatitis/Randomized clinical trial	30 participants	0	Infants suffering from diaper dermatitis assigned to HBM group and the control group were followed upward for 5 days and the efficiency of the treatment was evaluated by a 5-indicate scale rash severity.	In the command group 26.one% infants showed comeback, in HBM group—80%. HBM has decreased the incidence of anal dermatitis rash (p = 0.009).	A positive effect with topical awarding of HBM was plant.
Abou-Dakn et al. (2011) [10]	Painful and damaged nipples/No full randomized clinical trial	84 participants	14%	The efficacy of HBM and lanolin on pain and damage nipples was assessed on the 10-range Visual Analog Scale (VAS) and the Nipple Trauma Score (NTS) over 14 days after delivery.	Lanolin was more effective than HBM, including faster healing of nipple trauma and reducing nipple pain (p = 0.043).	No positive issue with topical awarding of HBM was plant.
Golshan and Hossein (2013) [eleven]	Umbilical cord care/Randomized clinical trial	316 participants	5%	The neonates were divided into three groups: Topical ethanol or HBM application twice a twenty-four hours, the control group kept the stump dry. Umbilical separation time and local infection frequency were considered.	Umbilical separation time in human milk group was significantly shorter (6.5 days) than in ethanol (8.94 days) (p < 0.0001) and drying groups (seven.54 days) (p < 0.003).	A positive effect with topical awarding of HBM was found.
Aghamohammadi et al. (2012) [12]	Umbilical cord care/Randomized clinical trial	152 participants	fourteen.v%	The umbilical separation time was compared in the group of topical HBM application (three times a day) and dry string care for x days.	Median time of string separation in human milk awarding group (150.95 ± 28.68 h) was significantly shorter than dry cord care group (180.93 ± 37.42 h) (p < 0.001).	A positive effect with topical application of HBM was found.
Abbaszadeh et al. (2016) [13]	Umbilical string care/Randomized clinical trial	174 participants	6.9%	The infant from HBM group received topical application of milk and group 2 chlorhexidine solution 4% to the umbilical stump 2 times a day. Follow-upward and visit at habitation were washed.	The mean cordseparation time in the human milk grouping (7.14 ± two.xv days) was shorter than the chlorhexidine group (xiii.28 ± vi.79 days) (p < 0.001).	A positive effect with topical awarding of HBM was found.
Ghaemi et al. (2014) [14]	Neonatal conjunctivitis/Randomized clinical trial	300 preterm neonates	10.6%	The intervention group with culture-negative center swab received two drops of HBM in each eye or erythromycin ointment (0.5%), control group—no handling. All neonates were followed for the occurrence of clinical conjunctivitis for 28 days.	The beneficial preventive effects of colostrum against neonatal conjunctivitis (p = 0.036).	A positive effect with awarding of HBM was found.
Asena et al. (2017) [xv]	Corneal epithelial wound/Randomized trial on mice model	24 female experimental corneal epithelial defect mice model	0	A fundamental corneal epithelial defect was created in mice and HBM, autologous serum, bogus tears four times a solar day was applied for 3 days. Histopathological and electron microscopy test was performed.	Topical human being breast milk drops causedfaster and better healing of central corneal epithelial defect than serum drops, artificial tears and in the control grouping (p < 0.001).	A positive effect with application of HBM was found.
Beynham et al. (2013) [16]	Antimicrobial effect on pediatric conjunctivitis/in vitro report	milk from 23 women/ix bacterial species tested	non applicable	The inhibitory effects of HBM against iii mutual ocular pathogens were assessed. Zones of inhibition by milk samples, sterile saline, and trimethoprim ophthalmic solution were measured	Growth of N gonorrhoeae, G catarrhalis, One thousand viridans was significantly inhibited (p ≤ 0.01) by human milk samples.	A positive result with application of HBM was institute.
Diego et al. (2016) [17]	Dry centre syndrome/Animal in vivo report	91 BALB/c mice	0	The animals with dry center syndrome were treated with HBM, nopal, nopal extract derivatives, or cyclosporine 4 times daily for 7 days. Punctate staining and preservation of corneal epithelial thickness were used as indices of therapeutic efficacy.	Reduction in corneal epithelial thickness was largely prevented by administration of HBM (33.two ± 2.5 μm).	HBM decreased epithelial impairment.
Mossberg et al. (2010) [18]	Float cancer handling/beast model and in vitro studies	vi C57BL mice float cancer model	0	Float tumors cells and float mice cancel models were instilled by Village. Effects of HAMLET on tumor size and apoptosis were analyzed.	HAMLET acquired a dose dependent decrease in MB49 cell viability in vitro. Five intravesical Village instillations significantly decreased tumor size anddelayed development in vivo compared to controls.	HAMLET from HBM delays bladder cancer development.
Puthia et al. (2014) [xix]	Colon cancer prevention and handling/animal model and in vitro studies	ApcMin/+ mice colorectal tumors model	0	HAMLET was given in therapeutic and prophylactic regimens. Tumor burden and brute survival were compared, and biochemistry and molecular methods were used to determine effects on colon cancer cells.	Peroral HAMLET assistants reduced tumor progression and mortality in ApcMin/+ mice.	Village from HBM delays colon cancer evolution.

We present a narrative summary of studies, rather than a meta-analysis, considering of the heterogeneity in measurement tools, populations, interventions, and design (whether qualitative or observational). The reporting in this review follows the Preferred Reporting Items for Systematic Reviews and MetaAnalysis (PRISMA) guidelines, where warranted.

3. Results

15 studies were of sufficient quality to be included in the systematic review. All of these had been published in peer-reviewed journals. The agreement between the reviewers was substantial: κ = 0.625 (p = 0.02). Seven studies were conducted in Iran, ii in the Usa, two in each of Turkey and Sweden, and one in each of Norway and Germany (Table i).

Ten of these 15 studies were randomized controlled trials (ii on experimental mice models), and one was a quasi-experimental written report. We also considered two in vitro studies and four with animal inquiry models. We decided to include these because they accept practical implication for clinical trials and, in our opinion, are examples of translational science.

Below we briefly draw the studies by medical trouble.

three.1. Skin Problems: Atopic Eczema and Diaper Dermatitis

Recently, a few studies have been published on the topical anti-inflammatory effects of human breast milk in the treatment of skin problems, such as atopic eczema and diaper dermatitis [half-dozen,20,21]. Our systematic review included five randomized clinical trials devoted to infants' peel problems, but the results were not consistent.

Berents and colleagues, in a small airplane pilot study, did not find any issue on eczema spots treated with topical application of fresh human milk. However, this clinical trial has some limitations. Get-go, it had a very small study population of six children; second, two of them were treated with their mother'south milk produced for a younger sibling. The mean age of the children was 18.5 months (ranging from 4 to 32) [5].

Kasrae et al. randomized 104 Iranian infants with atopic dermatitis for 21 days of treatment with i% hydrocortisone versus human milk. The frequency of healed infants was 81.5% and 76% in the human milk and one% hydrocortisone groups on mean solar day 21, respectively. The findings suggest that human milk can ameliorate atopic eczema with similar results and is as easy to use as 1% hydrocortisone ointment (p < 0.001), merely without the side-furnishings and cost [6].

The furnishings of topical application of human being milk and 1% hydrocortisone were also compared in the treatment of diaper dermatitis [7]. The randomized group consisted of 141 infants (aged 0–24 months). Parents received general communication about diaper rash intendance and were instructed to use the medication for vii days. The mothers assigned to employ milk were asked to rub milk gently on the afflicted expanse at the stop of each breastfeeding session. Hydrocortisone 1% in an ointment base was practical sparingly to clinically affected areas twice a mean solar day. The children were reassessed on days 3 and vii of the study. The presence of diaper rash was noted daily using a six-point calibration, and in both groups, was not significantly different after the topical application of either tested medication.HBM was as effective and safe as hydrocortisone 1% ointment alone (p < 0.001).

In the randomized controlled trials by Seifi et al., 30 Iranian infants (between 0 and 12 months of age) suffering from diaper dermatitis were divided into two matched groups: I applying their mother's milk 3 times a day to the afflicted surface area, and a command without any application for five days. The findings revealed positive effects of human being milk on the healing of diaper dermatitis and a meaning deviation between both groups. Out of xv infants with mild or moderate erythema, 80% improved during the five-twenty-four hours study, whereas in the control group 26.1% infants showed improvement (p = 0.009) [ix].

Gozen et al. tested the effectiveness of homo milk and bulwark cream (40% zinc oxide with cod liver oil formulation) on the healing of diaper dermatitis. The population of the trial included 63 term and preterm newborns with developed diaper dermatitis in neonatal intensive care units, divided into two groups. In that location were no statistically significant differences between the groups in terms of the mean number of clinical improvement days, merely the postlesion score in the barrier cream grouping was lower than in human milk group (p = 0.002) [8]. Every bit the researchers stated, neonatal intensive care units typically host infants with disorders and who are on antibiotics. Hence, negative findings can be hard to hash out and compare with other study data.

3.2. Nipple Problems

A common breastfeeding difficulty for mothers is painful nipples. One traditional non-pharmacological intervention to reduce nipple pain in breastfeeding women is topical treatment with expressed breast milk. Abou-Dakn et al. carried out clinical trials to evaluate the efficacy of lanolin versus breast milk on painful and damaged nipples during lactation [10]. They evaluated 84 lactating mothers from Berlin who developed nipple pain while breastfeeding within 72h later on delivery. The showtime group was instructed after each feed to express a few drops of breast milk and massage them into the nipples and areola, allowing to air-dry. The second group patted the nipples dry after each feeding session and applied a pea-sized amount of lanolin to the nipple and areola, keeping this surface area covered. During a number of visits over ii weeks, the nipple trauma score was used to evaluate healing rates and the visual analog scale (VAS) was employed to judge the pain intensity. Significantly lower pain levels were detected in the lanolin group, and these decreased with the continuation of treatment. Lanolin was more effective than HBM, including faster healing of nipple trauma (p = 0.043). According to many studies, the women who applied expressed breast milk had significantly lower perceptions of nipple hurting following 4 to 5 days of treatment than the women who applied lanolin. However, this beneficial effect was not maintained later half-dozen to seven days of treatment. At no assessment were there whatever grouping differences in nipple pain perceptions between the women who applied expressed breast milk and the women who had applied lanolin, warm compresses, or nothing [22].

3.3. Eye Issues

Treatment of ocular surface affliction with homo milk is documented in ancient Egyptian, Roman, Greek, and Byzantine texts and was traditionally used by mothers to care for infectious conjunctivitis. Ghaemi et al. have shown the beneficial preventive effects of colostrum confronting neonatal conjunctivitis on 89 breastfeeding neonates. The 269 preterm neonates were randomly divided into three groups: The first (n = 89) received two drops of colostrum in each eye, the second (north = 82) was treated with topical erythromycin ointment (0.5%), and the control group (97) received no treatment. The frequency of conjunctivitis was higher in the control grouping, followed by the group receiving topical application of colostrum and antibiotic (p = 0.003) [14]. Nonetheless, colostrum does not have potential hazards or side effects and is easily accessible without actress cost. Diego et al. observed that homo milk was able to preserve corneal epithelial thickness in the dry-middle mouse model. Epithelial damage, reflected in the punctate scores, decreased over four days of handling with milk. This was the first written report to demonstrate that human milk can preserve corneal epithelial thickness in a dry out-heart model, and that preservation of corneal epithelial thickness was comparable to topical cyclosporine [17]. Co-ordinate to the study of Asena et al., topical human breast milk drops caused faster and ameliorate healing of primal corneal epithelial defects in a mouse model than in the example of treatment with serum drops or artificial tears or in the control group (p < 0.001) [15]. They concluded that the rich contents of man breast milk may be an alternative to epithelial healers and artificial tears.

iii.iv. Umbilical Cord Care

Chest milk is widely reported to be used for umbilical string intendance in developing countries, as evidenced by numerous publications. Since 1998, the World Health System (WHO) has advocated the use of dry umbilical cord intendance in loftier-resource settings only has also recommended research into the use of breast milk and colostrum in umbilical cord care [23]. There are several reports of the effectiveness of applying female parent's milk in profitable umbilical string separation [12,24]. All the same, in the PubMed database between 2010 and 2018, simply iii studies were randomized controlled trials. All were published in peer-reviewed journals and were conducted in Iran (see Table 1).

Aghamohammadi et al. randomized 130 singletons, all mature and healthy newborns born in hospital, and compared the effect of topical application of human milk and dry cord care on umbilical cord separation time. Newborns were breastfed. Mothers were asked non to embrace the cord with diapers and not to bath the child until the cord had separated. All mothers received instructions, a grade for recording symptoms of infection and cord bleeding, and a course for observation on the progress of care. The human milk group dropped milk on the remaining part of the cord and the cut border, letting information technology dry, three times a day for two days after separation of the string. Two days afterward string separation, a dr. checked the string. The median time of the cord separation was 150.95 ± 28.68 hours in the human milk topical application group and 180.93 ± 37.42 hours in the dry cord care group (p = 0.001). The median number of haemorrhage days after cord separation was 1.two ± 2.33 and 3.ane ± iii.77, respectively [12].

In the written report of Golshan et al., 300 healthy neonates, delivered normally or by Cesarean section, were divided into three random groups, in which ethanol, their mother's milk, or dry cord care was applied. In the milk grouping, mothers washed the umbilical cord stump with their milk two times a day. Umbilical separation time in neonates of the human milk grouping was six.5 ± 1.93 days, whereas in the ethanol and dry intendance group this was viii.94 ± 2.39 and seven.54 ± 2.37 days, respectively. The frequency of omphalitis was not significantly different between the iii groups. Umbilical separation time in the man milk grouping was significantly shorter than in the ethanol (p < 0.0001) and drying groups (p < 0.003) [xi].

In a clinical trial past Abbaszadeh et al., 162 healthy, hospital-borne neonates were assigned to two groups, where string care was performed using human being milk or chlorhexidine. Human milk was applied to the umbilical cord every twelve hours for days after separation. The shortest cord separation fourth dimension was three days in the topical human milk group (7.xiv ± 2.xv), while the longest was 53 days in chlorhexidine group (13.28 ± half-dozen.79) (p < 0.001) [13].

All three studies recommend topical application of female parent's milk for umbilical string stump care, which leads to shorter cord separation time and tin exist used every bit an easy, cheap, natural, and noninvasive means of cord care.

three.v. The Antitumoricidal Outcome of Hamlet

1 instance of translational medicine is the topical application of α-lactalbumin-oleic acrid, a natural product from breast milk. The complex called human alpha-lactalbumin made lethal to tumor cells (Hamlet) was discovered by the Svanborg grouping when they were studying antiadhesive molecules in human milk [25].

Hamlet is formed during low-pH atmospheric precipitation of the casein fraction, which allows for partial unfolding of the α-lactalbumin structure and binding with the fatty acrid. HAMLET triggers rapid carcinoma cell detachment in vitro and in cancer patients after topical administration of the lyophilized circuitous. To form HAMLET, α-lactalbumin is obtained from human milk past chromatography. The partially unfold protein is later bound to oleic acid on an ion-exchange matrix, and the complex is eluted with common salt, purified, lyophilized, and frozen in aliquots for instillation [26].

The therapeutic efficacy of Village has been demonstrated through in vitro research in brute models of glioblastoma, bladder cancer, and intestinal cancer; and in clinical studies targeting float cancers and skin papillomas [27,28]. Local Village infusion was shown to delay the evolution of tumors and prolong survival in fauna models of man cancer. In the study of Mossberg et al., groups of C57BL/half dozen mice with MB49-implanted murine bladder cancer cells were given instillations of Hamlet or phosphate buffered saline PBS for viii days. The HAMLET treated mice lacked detectable tumors more often than the controls (33% vs. 0%, p < 0.02) and the tumors were significantly reduced (mean score 1.9 vs. two.five, respectively; p < 0.02) [18]. Puthia et al. tested whether Hamlet could be used for colon cancer therapy. Peroral HAMLET administration caused a meaning reduction in the number of small intestinal tumors and in tumor size (p < 0.0001 for full tumor count), reduced polyps by about 58% (p = 0.0001), and improved survival (p = 0.0103) over the control grouping mice.

Through gene set enrichment assay, the researchers concluded that the rubber and therapeutic effects of Village are accompanied by well-defined serial of stable changes in gene expression, affecting Wnt signaling and β-catenin, glycolysis, oxidative phosphorylation, and lipid metabolism in tumor tissue [19].

The same complex showed strong bactericidal activity against specific pathogens of the oral cavity and respiratory rail, with the highest action against the gram-positive organism Streptococcus pneumoniae by prison cell shrinkage, DNA condensation, and Deoxyribonucleic acid degradation [29].

four. Discussion

The transfer of traditional medical knowledge is an ongoing process. Information technology is important both for the preservation of traditional natural medicine, but also in the search for novel agents in handling. Dwelling house remedies are generally believed to exist natural means to cure minor illnesses or conditions. They are ordinarily cultural practices, traditions, community, or folk remedies that take been passed down from generation to generation or from person to person. Withal, information technology should be kept in mind that there is not necessarily any medical proof that any of these treatments work, or whether they can cause more harm than good. Human being milk is considered to be the gold standard in babe nutrition, providing optimal nutrients for normal growth and development. Apart from its nutritional benefits, homo milk contains multiple bioactive and immunomodulatory components. The latter of these include growth and immunological factors, as well every bit micro-RNAs, cellular components such every bit leukocytes, epithelial cells, progenitor cells, and stem cells [30]. Furthermore, breast milk is also a continuous source of commensal and beneficial leaner, including lactic acid bacteria and bifidobacteria [31,32]. The discovery of stem cells, the HAMLET circuitous, and probiotic bacteria in breast milk has resulted in increased interest in human breast milk as a natural medicine. The studies described here advise rubber and cost-effective non-nutritional uses of mothers' chest milk, though farther evaluation of effectively is needed. Chest milk has natural antibacterial properties, and then it can be used to care for a range of pare problems, including cuts and scrapes.

Common skin problems may appear during lactation and breastfeeding, especially affecting the nipple, areola, and breast. Some medications used in the handling of skin conditions are unsuitable during lactation. It has been shown that expressing a few drops of milk and rubbing them gently into the sore nipples, and then allowing it to dry out naturally, takes advantage of the healing properties of human milk. Many studies take indicated that bioactive components of human milk and microbiota have promise as adjuvants for wound healing [33,34]. From lesions of the corneal epithelium to lacerations of the pare, milk-treated groups healed faster than controls.

Breast milk is used in many cultures for skin irritations. Breast milk involves no hazard of allergy, contains antibodies, epidermal growth factor (EGF), and erythropoietin, which may promote the growth and repair of pare cells. Homo milk is a source of commensal bacteria that can play an anti-infectious, immunomodulatory role. Their possible function in the acceleration of conditions for skin biofilm formation can open new perspectives for the prevention and treatment of peel and wound healing diseases. Interestingly, the analysis of Simpson et al. showed that miRNAs are possible mediators of the observed preventative furnishings of atopic dermatitis [35].

The concentration, regulation, and individual variation between bioactive element, allowed factors, various progenitor and mature jail cell types, and phase of lactation are non well established. Complication and variability in homo milk composition, and infants' responses to many homo milk constituents may as well explain some of the conflicting results of studies evaluating the effects of non-nutritional uses of human milk.

The studies considered here vary in methodology and in definition of outcomes, which leads to considerable heterogeneity. Human being milk composition varies both within and betwixt individuals, and this may partially explicate the conflicting data.

However, the use of chest milk in the treatment of inflamed or injured optics is not applicable in all cases. It should rather serve as complementary therapy, and non the only mode of treatment. At our nowadays level of knowledge, non-nutritional uses of breast milk are certainly better suited to prevention than to a medicated procedure. Yet, in areas where mothers and infants practice non have gear up access to medicine, such as in developing countries, the awarding of breast milk is often a determining cistron in babe recovery and survival.

4.1. Implications for Future Research

Fresh whole human milk and its components accept potential as a novel therapeutic tool in the treatment of many diseases. In our opinion, the future implications of non-nutritional application are associated with item components of breast milk, rather than with the whole milk.

In Hakansson's study of the antimicrobial activity of human milk, a complex of α-lactalbumin and oleic acid induced apoptosis in tumor cells without affecting healthy differentiated cells. Village is a tumoricidal protein–lipid complex from homo milk with broad furnishings against cancer cells of different origins. The mechanism of its action is unusual, every bit the circuitous interacts with a number of molecular targets and cellular components. Chiefly, HAMLET does not have any toxic furnishings on healthy tissues in the treated patients and animals. Hamlet has been shown to exist safe and effective in humans in ii proof-of-concept human clinical trials: Convincing therapeutic efficacy was demonstrated in a topical skin papilloma study and in patients with bladder cancer (ClinicalTrials.gov Identifier: {"blazon":"clinical-trial","attrs":{"text":"NCT03560479","term_id":"NCT03560479"}}NCT03560479) [33]. Publications on HAMLET are related to the establishment of a Swedish company, HAMLET Pharma, and the increased number of patents regarding this molecule. Based on these discoveries, Hamlet Pharma is developing natural tumor-killing drugs based on molecules with tumor selectivity. A Village patent portfolio has been established with a number of patents issued worldwide. Intellectual property rights include patents covering the manufacturing and use of Village and substances derived from HAMLET "second generation drug candidates".

Many studies highlight progenitor and breast milk stem cells. The presence of stalk cells in human milk poses numerous questions and implications for breastfeeding, newborn, and maternal wellness, but also opens a new perspective of future potential applications of these cells in personal and regenerative medicine. The goals of future research should be to assess the function, potency, and therapeutic value of breast milk cells—including cell therapy for futurity applications—and should make up one's mind the straight or indirect effects of breast milk cell components on promoting immunological tolerance and newborn evolution, and also on providing effective and complementary treatment of diaper rash, atopic eczema, diaper dermatitis, umbilical cord separation, and eye bug. Without any uncertainty, future research on these topics will demand to involve show-based medicine and clinical trials.

4.2. Limitations

Due to the limited and heterogeneous torso of evidence that included animal studies, human intervention studies, and observational human studies, the risk of bias assessment for private studies was not performed. The overall torso of evidence was narratively discussed.

This article is limited past its accent on papers published in English in journal databases, so many useful local ethnomedical studies may have been missed. Evidence-based medicine focuses more than on new approaches than on developing traditional folk and ethnobiological data, so many promising intervention studies are non published in papers indexed in PubMed with loftier impact cistron. Information technology is unclear whether a lack of institutional support and funding for clinical trials of natural products might be critical in the depression number of studies.

four.3. Conclusions

The findings of this review provide information almost possible non-nutritional uses of chest milk in postnatal care. Chest milk is a natural agent and is biologically suitable for the body, having no side effects; it is always available and can be used in all social and economic groups of club. The wellness implications of milk components—such as macronutrients, biologically active factors, and somatic cells—remain unknown or not well understood. The positive effects of HBM found by in vitro and animal studies must be substantiated by findings from clinical studies. The most reliable clinical studies for assessing the benefits of HBM are randomized, double-blinded, multicenter controlled trials but to appointment, they are very scarce.

Non-nutritional uses of homo breast milk can be considered examples of personalized medicine. Further research including adult countries is recommended to discover or ostend the results and to evaluate the effects of traditional therapies. This noesis may also have the effect of disarming mothers to continue to breastfeed with their own milk, as a substance that possesses extraordinary properties, not but for nutrition.

Author Contributions

One thousand.W.-Z. designed the model and analyzed and processed the information, drafted the manuscript; E.Thou.-E.-H. analyzed and candy the data, performed the analysis; E.West. designed the figures. All authors provided disquisitional feedback and helped shape the research, analysis, and manuscript.

Funding

The APC was funded by Medical University of Warsaw.

Conflicts of Interest

Authors declare no conflict of involvement.

References

ane. Kramer Thou.Due south. "Breast is best": The testify. Early Hum. Dev. 2010;86:729–732. doi: x.1016/j.earlhumdev.2010.08.005. [PubMed] [CrossRef] [Google Scholar]

2. Allam N., Megrin W., Talat A. The consequence of topical application of mother milk on separation of umbilical cord for newborn babies. Am. J. Nurs. Sci. 2015;4:288–296. doi: 10.11648/j.ajns.20150405.xvi. [CrossRef] [Google Scholar]

3. Mahrous Due east.S., Darwish M.M., Dabash S.A., Marie I., Abdelwahab S.F. Topical application of human milk reduces umbilical cord separation time and bacterial colonization compared to ethanol in newborns. Transl. Biomed. 2012;three:4. [Google Scholar]

iv. Approach R., Martín Five., Maldonado A., Jiménez E., Fernández L., Rodríguez J.G. Treatment of infectious mastitis during lactation: Antibiotics versus oral assistants of Lactobacilli isolated from breast milk. Clin. Infect. Dis. 2010;50:1551–1558. doi: 10.1086/652763. [PubMed] [CrossRef] [Google Scholar]

5. Berents T.50., Rønnevig J., Søyland E., Gaustad P., Nylander M., Løland B.F. Topical handling with fresh man milk versus emollient on atopic eczema spots in immature children: A minor, randomized, divide body, controlled, blinded airplane pilot study. BMC Dermatol. 2015;xv:7. doi: 10.1186/s12895-015-0027-ix. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]

6. Kasrae H., AmiriFarahani 50., Yousefi P. Efficacy of topical application of human breast milk on atopic eczema healing amid infants: A randomized clinical trial. Int. J. Dermatol. 2015;54:966–971. doi: ten.1111/ijd.12764. [PubMed] [CrossRef] [Google Scholar]

7. Farahani L.A., Ghobadzadeh Thousand., Yousefi P. Comparison of the effect of human being milk and topical hydrocortisone one% on diaper dermatitis. Pediatr. Dermatol. 2013;xxx:725–729. doi: 10.1111/pde.12118. [PubMed] [CrossRef] [Google Scholar]

8. Gozen D., Caglar S., Bayraktar S., Atici F. Diaper dermatitis care of newborns homo breast milk or barrier cream. J. Clin. Nurs. 2014;23:515–523. doi: 10.1111/jocn.12047. [PubMed] [CrossRef] [Google Scholar]

9. Seifi B., Jalali S., Heidari M. Cess Effect of Breast Milk on Diaper Dermatitis. Dermatol. Rep. 2017;9:7044. doi: 10.4081/dr.2017.7044. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]

10. Abou-Dakn M., Fluhr J.West., Gensch Grand., Wöckel A. Positive consequence of HPA lanolin versus expressed breastmilk on painful and damaged nipples during lactation. Skin Pharmacol. Physiol. 2011;24:27–35. doi: x.1159/000318228. [PubMed] [CrossRef] [Google Scholar]

11. Golshan M., Hossein Northward. Impact of ethanol, dry care and man milk on the time for umbilical string separation. J. Pak. Med. Assoc. 2013;63:1117–1119. [PubMed] [Google Scholar]

12. Aghamohammadi A., Zafari Thou., Moslemi L. Comparing the effect of topical application of human milk and dry out cord care on umbilical cord separation time in good for you newborn infants. Iran J. Pediatr. 2012;22:158–162. [PMC free article] [PubMed] [Google Scholar]

13. Abbaszadeh F., Hajizadeh Z., Jahangiri K. Comparing the Impact of Topical Application of Homo Milk and Chlorhexidine on Cord Separation Time in Newborns. Pak. J. Med. Sci. 2016;32:239–243. doi: 10.12669/pjms.321.8223. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]

14. Ghaemi Due south., Navaei P., Rahimirad Southward., Behjati M., Kelishadi R. Evaluation of preventive effects of colostrum confronting neonatal conjunctivitis: A randomized clinical trial. J. Educ. Wellness Promot. 2014;3:63. doi: 10.4103/2277-9531.134776. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

xv. Asena L., Suveren East.H., Karabay G., Dursun-Altinors D. Human Chest Milk Drops Promote Corneal Epithelial Wound Healing. Curr. Eye Res. 2017;42:506–512. doi: ten.1080/02713683.2016.1223318. [PubMed] [CrossRef] [Google Scholar]

16. Baynham J.T., Moorman M.A., Donnellan C., Cevallos Five., Keenan J.D. Antibacterial outcome of human milk for common causes of paediatric conjunctivitis. Br. J. Ophthalmol. 2013;97:377–379. doi: ten.1136/bjophthalmol-2012-302833. [PubMed] [CrossRef] [Google Scholar]

17. Diego J.L., Bidikov L., Pedler Chiliad.Thousand., Kennedy J.B., Quiroz-Mercado H., Gregory D.Yard., Petrash J.M., McCourt E.A. Effect of human milk as a treatment for dry eye syndrome in a mouse model. Mol. Vis. 2016;22:1095–1102. [PMC free article] [PubMed] [Google Scholar]

18. Mossberg A.Thou., Hou Y., Svensson Grand., Holmqvist B., Svanborg C. Hamlet handling delays bladder cancer development. J. Urol. 2010;183:1590–1597. doi: 10.1016/j.juro.2009.12.008. [PubMed] [CrossRef] [Google Scholar]

19. Puthia M., Storm P., Nadeem A., Hsiung S., Svanborg C. Prevention and handling of colon cancer by peroral administration of Village (human α-lactalbumin made lethal to tumour cells) Gut. 2014;63:131–142. doi: 10.1136/gutjnl-2012-303715. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

xx. Chaumeil C., Liotet South., Kogbe O. Handling of severe middle dryness and problematic eye lesions with enriched bovine colostrum lactoserum. Adv. Exp. Med. Biol. 1994;350:595–599. [PubMed] [Google Scholar]

21. Mohammadzadeh A., Farhat A., Esmaeily H. The issue of breast milk and lanolin on sore nipples. Saudi Med. J. 2005;26:1231–1234. [PubMed] [Google Scholar]

22. Pugh Fifty.C., Buchko B.L., Bishop B.A., Cochran J.F., Smith L.R., Lerew D.J. A comparison of topical agents to relieve nipple pain and enhance breastfeeding. Nativity. 1996;23:88–93. doi: ten.1111/j.1523-536X.1996.tb00835.x. [PubMed] [CrossRef] [Google Scholar]

23. World Health Organization . Care of the Umbilical Cord: A Review of the Evidence. WHO; Geneva, Switzerland: 1998. p. nineteen. [Google Scholar]

24. Karumbi J., Mulaku M., Aluvaala J., English Grand., Opiyo Northward. Topical umbilical string intendance for prevention of infection and neonatal mortality. Pediatr. Infect. Dis. J. 2013;32:78–83. doi: 10.1097/INF.0b013e3182783dc3. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]

25. Håkansson A., Zhivotovsky B., Orrenius South., Sabharwal H., Svanborg C. Apoptosisinduced by a human being milkprotein. Proc. Natl. Acad. Sci. USA. 1995;92:8064–8068. doi: 10.1073/pnas.92.17.8064. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

26. Trulsson M., Yu H., Gisselsson L., Chao Y., Urbano A., Aits S., Mossberg A.Thou., Svanborg C. Hamlet Binding to α-Actinin Facilitates Tumor Cell Detachment. PLoS I. 2011;6:e17179. doi: 10.1371/journal.pone.0017179. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

27. Ho J.C.Due south., Nadeem A., Svanborg C. Village—A poly peptide-lipid complex with broad tumoricidal action. Biochem. Biophys. Res. Commun. 2017;482:454–458. doi: 10.1016/j.bbrc.2016.10.092. [PubMed] [CrossRef] [Google Scholar]

28. Rath A.E., Duff A.P., Håkansson A.P., Vacher C.Due south., Li G.J., Knott R.B., Church W.B. Structure and potential cellular targets of HAMLET-similar anti-cancer compounds made from milk components. J. Pharm. Pharm. Sci. 2015;18:773–824. doi: x.18433/J3G60C. [PubMed] [CrossRef] [Google Scholar]

29. Hakansson A.P., Roche-Hakansson H., Mossberg A.Chiliad., Svanborg C. Apoptosis-similar death in leaner induced by Hamlet, a human milk lipid-protein complex. PLoS I. 2011;six:e17717. doi: 10.1371/journal.pone.0017717. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]

30. Hassiotou F., Geddes D.T. Immune prison cell-mediated protection of the mammary gland and the infant during breastfeeding. Adv. Nutr. 2015;6:267–275. doi: 10.3945/an.114.007377. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

31. McGuire M.Chiliad., McGuire One thousand.A. Human being milk: Mother nature'south prototypical probiotic food. Adv. Nutr. 2015;half dozen:112–123. doi: x.3945/an.114.007435. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]

32. Witkowska-Zimny One thousand., Kaminska-El-Hassan Due east. Cells of human breast milk. Cell Mol. Biol. Lett. 2017;22:eleven. doi: 10.1186/s11658-017-0042-4. [PMC gratis commodity] [PubMed] [CrossRef] [Google Scholar]

33. Gustafsson L., Leijonhufvud I., Aronsson A., Mossberg A.1000., Svanborg C. Treatment of pare papillomas with topical alpha-lactalbumin-oleic acid. N. Engl. J. Med. 2004;350:2663–2672. doi: x.1056/NEJMoa032454. [PubMed] [CrossRef] [Google Scholar]

34. Heikkila Thou.P., Saris P.Eastward. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J. Appl. Microbiol. 2003;95:471–478. doi: 10.1046/j.1365-2672.2003.02002.ten. [PubMed] [CrossRef] [Google Scholar]

35. Simpson M.R., Brede Chiliad., Johansen J., Johnsen R., Storrø O., Sætrom P., Øien T. Human being Breast MilkmiRNA, Maternal Probiotic Supplementation and Atopic Dermatitis in Offspring. PLoS ONE. 2015;x:e0143496. doi: 10.1371/journal.pone.0143496. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

russoutemainner.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567207/